Inmune Bio, Inc. (INMB) Form 8-K — Jul 1, 2026
Inmune Bio entered into an inducement agreement and a second amendment to its April 2024 common stock purchase warrants. The company offered holders the opportunity to exercise 50% of their warrants at a reduced exercise price of $1.40 per share, a decrease from the original $1.95. Holders agreed to exercise 647,112 warrants for an aggregate of 647,112 shares of common stock. In consideration for the reduced price, Inmune Bio expects to receive approximately $905,957 in cash proceeds from the transaction.
Key figures
- Gross Proceeds
- 905957
- Offering Price
- 1.4
- Shares Offered
- 647112
- New Maturity Date
- December 31, 2027
- Warrants Exercised
- 647112
- Original Maturity Date
- June 30, 2026
- Reduced Exercise Price
- 1.4
- Original Exercise Price
- 1.95
Price after filing
Close on the filing date to close N calendar days later (from $1.68). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.